Drug Alerts - 2026
Date published:
Last updated:
Drug alerts issued by DoH during 2026
Documents
- PHC-01-2026 - Class 2 Medicines Recall Paliperidone Mercury Pharma 50 mg and 75mg prolonged-release suspension for injection in pre-filled syringe EL(26)A/01
- PHC-02-2026 - Class 3 Medicines Recall - Fingolimod Glenmark 0.5 mg Hard Capsules EL(26)A/02
- PHC-03-2026 - Class 4 medicines defect information, EL(26)A/03 - Ocumont Eye Ointment 1% ww batch B0866
- PHC-04-2026 - Class 4 medicines defect information, EL(26)A/04 Arixtra 1.5 mg/0.3 ml solution for injection, pre-filled syringe
- PHC-05-2026 - Class 1 Medicines Recall - Eaststone Limited, Quetiapine oral suspension, all strengths, (unlicensed medicine), NatPSA/2026/002/MHRA
- PHC-06-2026 - Class 2 Medicines Recall - Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent ) EL(26)A/05
- PHC-07-2026 - Class 2 Medicines Recall of two batches of Baclofen 10mg/5ml Oral Solution
- PHC-08-2026 - Class 3 Recall of four batches Ibuprofen Ibucalm 200mg tablets DMRC Ref-38319360
- PHC-09-2026 - CLASS 3 MEDICINES RECALL, EL(26)A/08 – NORGINE MOVICOL Ease Citrus Powder for oral solution 13.7g
- PHC-10-2026 - Class 2 Medicines Recall KidNaps (Melatonin) 1mg in 1ml Oral Solution EL(26)A/09
- PHC-11-2026 - Class 4 Medicines Defect Information EL(26)A/10 Dropodex 0.1% w/v Eye Drops, solution
- PHC-12-2026 - CLASS 2 MEDICINES RECALL, CRESCENT PHARMA LIMITED, RAMIPRIL 5 MG CAPSULES, EL(26)A/11 Ramipril 5 mg Capsules